Survival patterns among lymphoma patients with a family history of lymphoma

Journal of Clinical Oncology

Volumn 26, Issue 30, 2008, Pages 4958-4965

  Anderson, Lesley Ann ^a   Pfeiffer, Ruth M ^a   Rapkin, Joshua S ^a   Gridley, Gloria ^a   Mellemkjaer, Lene ^a   Hemminki, Kari ^a   Björkholm, Magnus ^a   Caporaso, Neil E ^a   Landgren, Ola ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENMARK; FAMILIAL CANCER; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HODGKIN DISEASE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RELATIVE; SWEDEN; T CELL LYMPHOMA; AGE DISTRIBUTION; B CELL LEUKEMIA; COHORT ANALYSIS; GENETICS; MIDDLE AGED; MORTALITY; REGISTER; SEX RATIO; SURVIVAL RATE;

AGE DISTRIBUTION; AGED; COHORT STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REGISTRIES; SEX DISTRIBUTION; SURVIVAL RATE; SWEDEN;

EID: 54449099559     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.6571     Document Type: Article

References (58)

1. Cannon-Albright LA, Thomas A, Goldgar DE, et al: Familiality of cancer in Utah. Cancer Res 54:2378-2385, 1994
2. Capalbo S, Trerotoli P, Ciancio A, et al: Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: Relevance of the degree of familial linkage. Eur J Haematol 65:114-117, 2000
3. Cartwright RA, Bernard SM, Bird CC, et al: Chronic lymphocytic leukaemia: Case control epidemiological study in Yorkshire. Br J Cancer 56:79-82, 1987
4. Chang ET, Smedby KE, Hjalgrim H, et al: Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst 97:1466-1474, 2005
5. Goldin LR, Pfeiffer RM, Li X, et al: Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: Results from the Swedish Family-Cancer Database. Blood 104: 1850-1854, 2004
6. Ishibe N, Sgambati MT, Fontaine L, et al: Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry. Leuk Lymphoma 42:99-108, 2001
7. Kerber RA, O'Brien E: A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103:1906-1915, 2005
8. Linet MS, Van Natta ML, Brookmeyer R, et al: Familial cancer history and chronic lymphocytic leukemia: A case-control study. Am J Epidemiol 130:655-664, 1989
9. Pottern LM, Linet M, Blair A, et al: Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res 15:305-314, 1991
10. Radovanovic Z, Markovic-Denic L, Jankovic S: Cancer mortality of family members of patients with chronic lymphocytic leukemia. Eur J Epidemiol 10:211-213, 1994
11. Yuille MR, Matutes E, Marossy A, et al: Familial chronic lymphocytic leukaemia: A survey and review of published studies. Br J Haematol 109:794-799, 2000
12. Lindelof B, Eklund G: Analysis of hereditary component of cancer by use of a familial index by site. Lancet 358:1696-1698, 2001
13. Shugart YY, Hemminki K, Vaittinen P, et al: A genetic study of Hodgkin's lymphoma: An estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet 106:553-556, 2000
14. Westergaard T, Melbye M, Pedersen JB, et al: Birth order, sibship size and risk of Hodgkin's disease in children and young adults: A population-based study of 31 million person-years. Int J Cancer 72:977-981, 1997
15. Mack TM, Cozen W, Shibata DK, et al: Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332:413-418, 1995
16. Kerzin-Storrar L, Faed MJ, MacGillivray JB, et al: Incidence of familial Hodgkin's disease. Br J Cancer 47:707-712, 1983
17. Haim N, Cohen Y, Robinson E: Malignant lymphoma in first-degree blood relatives. Cancer 49:2197-2200, 1982
18. Bernard SM, Cartwright RA, Darwin CM, et al: Hodgkin's disease: Case control epidemiological study in Yorkshire. Br J Cancer 55:85-90, 1987
19. Grufferman S, Cole P, Smith PG, et al: Hodgkin's disease in siblings. N Engl J Med 296:248-250, 1977
20. Goldgar DE, Easton DF, Cannon-Albright LA, et al: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608, 1994
21. Goldin LR, Pfeiffer RM, Gridley G, et al: Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100:1902-1908, 2004
22. Hemminki K, Li X, Czene K: Familial risk of cancer: Data for clinical counseling and cancer genetics. Int J Cancer 108:109-114, 2004
23. Paltiel O, Schmit T, Adler B, et al: The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: Results and limitations of a registry-linked study. Cancer 88:2357-2366, 2000
24. Altieri A, Bermejo JL, Hemminki K: Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: The Swedish Family-Cancer Database. Blood 106:668-672, 2005
25. Cartwright RA, McKinney PA, O'Brien C, et al: Non-Hodgkin's lymphoma: Case control epidemiological study in Yorkshire. Leuk Res 12:81-88, 1988
26. Chatterjee N, Hartge P, Cerhan JR, et al: Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 13:1415-1421, 2004
27. Goldin LR, Landgren O, McMaster ML, et al: Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev 14:2402-2406, 2005
28. Mensah FK, Willett EV, Ansell P, et al: Non-Hodgkin's lymphoma and family history of hematologic malignancy. Am J Epidemiol 165:126-133, 2007
29. Zhu K, Levine RS, Gu Y, et al: Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States). Cancer Causes Control 9:77-82, 1998
30. Casey R, Brennan P, Becker N, et al: Influence of familial cancer history on lymphoid neoplasms risk validated in the large European case-control study epilymph. Eur J Cancer 42:2570-2576, 2006
31. Cuttner J: Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia. Cancer Invest 10:103-109, 1992
32. Skibola CF, Curry JD, Nieters A: Genetic susceptibility to lymphoma. Haematologica 92:960-969, 2007
33. Goldin LR, McMaster ML, Ter-Minassian M, et al: A genome screen of families at high risk for Hodgkin lymphoma: Evidence for a susceptibility gene on chromosome 4. J Med Genet 42:595-601, 2005
34. Rudd MF, Sellick GS, Webb EL, et al: Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 108:638-644, 2006
35. Jamroziak K, Balcerczak E, Smolewski P, et al: MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol Rep 58:720-728, 2006
36. Hohaus S, Massini G, D'Alo' F, et al: Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis. Clin Cancer Res 9:3435-3440, 2003
37. Lan Q, Zheng T, Shen M, et al: Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet 121:161-168, 2007
38. Purdue MP, Lan Q, Kricker A, et al: Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales Non-Hodgkin Lymphoma study. Carcinogenesis 28:704-712, 2007
39. Shen M, Zheng T, Lan Q, et al: Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet 119:659-668, 2006
40. Lee JJ, Kim DH, Lee NY, et al: Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. Br J Haematol 137:329-336, 2007
41. Warzocha K, Ribeiro P, Bienvenu J, et al: Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91:3574-3581, 1998
42. Juszczynski P, Kalinka E, Bienvenu J, et al: Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 100:3037-3040, 2002
43. Lech-Maranda E, Baseggio L, Bienvenu J, et al: Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103:3529-3534, 2004
44. Caporaso NE: Integrative study designs-next step in the evolution of molecular epidemiology? Cancer Epidemiol Biomarkers Prev 16:365-366, 2007
45. Staudt LM: Gene expression profiling of lymphoid malignancies. Annu Rev Med 53:303-318, 2002
46. Li L: Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information. Bioinformatics 22:466-471, 2006
47. Gemmati D, Ongaro A, Tognazzo S, et al: Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: Association with toxicity and survival. Haematologica 92:478-485, 2007
48. Rosenlof RC, Lemon HM, Rigby PG: Familial factors relating to prognosis of leukemia and lymphoma. Natl Cancer Inst Monogr 34:283-289, 1971
49. Mauro FR, Giammartini E, Gentile M, et al: Clinical features and outcome of familial chronic lymphocytic leukemia. Haematologica 91:1117-1120, 2006
50. Landgren O, Linet MS, McMaster ML, et al: Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: A population-based case-control study. Int J Cancer 118:3095-3098, 2006
51. Hemminki K, Li X, Plna K, et al: The nationwide Swedish family-cancer database-updated structure and familial rates. Acta Oncol 40:772-777, 2001
52. Skarle A: Flergenerationsregistret. Stockholm, Sweden, Statistics Sweden, Population Statistics, 2001
53. The National Board of Health and Welfare: Cancer Incidence in Sweden 2003. Stockholm, Sweden, National Board of Health and Welfare, 2004
54. Storm HH, Michelsen EV, Clemmensen IH, et al: The Danish Cancer Registry- history, content, quality and use. Dan Med Bull 44:535-539, 1997
55. Nenova IS, Karnolski IN, Mateva NG, et al: Familial study of chronic lymphocytic leukemia: Aggregation of different malignant processes in families with individuals affected with chronic lymphocytic leukemia. Folia Med (Plovdiv) 48:11-16, 2006
56. Zinzani PL: Traditional treatment approaches in B-cell non-Hodgkin's lymphoma. Leuk Lymphoma 44:S6-S14, 2003 (suppl 4)
57. Varterasian ML, Graff JJ, Severson RK, et al: Non-Hodgkin's lymphoma: An analysis of the Metropolitan Detroit SEER database. Cancer Invest 18:303-308, 2000
58. Turesson I, Linet MS, Bjorkholm M, et al: Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer 121:2260-2266, 2007